Sunday, 26 May 2019

Market Survey News

  • Top 5 healthcare trends

    Market Survey |  Opinion | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2014

    Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their own health is on the rise, urging healthcare organizations to reinforc...Read more

  • North China Pharma integrates R&D strength in its system

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally engaged in the production and distribution of pharmaceuticals and its ma...Read more

  • Asia faces an acute skills gap challenge

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a hurdle for Asia to emerge as a center of research and innovation. Co...Read more

  • Mindray goes on acquisition spree for strong portfolio

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 22 Jun, 2012

    Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in net revenue in 2011. The revenue jumped from $704.3 million in 2010 ...Read more

  • Resmed dominates the niche sleep disorder market

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, ResMed continues to increase its effort to build awareness abou...Read more

  • Sinopharm demonstrates king size growth, yet again

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a large chunk of market share and widened its geographical coverage of...Read more

  • Cipla nurtures global vision for affordable drugs

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market. Without missing any opportunity to serve the healthcare industry in...Read more

  • Asia bioscience grows 11 percent, crosses $150 bn

    Market Survey |  Analysis | By Nandita Singh | 0 Comment | 21 Jun, 2013

    During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording a double-digit growth of 11.07 percent over $139 billion of 2011. Aro...Read more

  • Dr. Reddy's makes a mark in the US generics market

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 percent. Dr. Reddy's generic version of fondaparinux, used for prophylax...Read more

  • Aurobindo Pharma revamps strategy to accelerate growth

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo has developed its market base in over 125 countries across the globe ...Read more

  • ResMed builds on partnerships for growth

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

    Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisitions and product expansion in the European region in 2011. ResMed took...Read more

  • Bioscience Industry clocks $139 bn, grows 8.37%

    Market Survey |  Analysis | By Nandita Singh | 0 Comment | 03 Jul, 2012

    The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 2009 slowdown, it was a single digit show in 2011 too. The industry reco...Read more

  • Sigma Pharma leverages on its pharmacy business

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained its No 3 rank slot in the BioSpectrum Asia list of Top 20 publicly lis...Read more

  • Shenzhen Neptunus invests in drug innovation

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical products in China. The company is known for manufacturing approximately 400 ...Read more

  • China holds largest pharma revenue share in APAC

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest share of the market. According to the BioSpectrum Top 20 survey, the y...Read more

  • China secures rank 1 in terms of total company revenues

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. Table legend:Country R...Read more

  • China, Australia dominate APAC pharma market

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 2011, riding on various factors, including an ever increasing population...Read more

  • China National Accord's R&D strategy begins to pay-off

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scientific development by implementing new medical reforms fostered by Chine...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls